Ambryon Biosciences

pCMV-dR8.2 dvpr

HIV-1 packaging plasmid, named dR8.2 with vpr deleted: a CMV enhancer and promoter drives HIV-1 gag and pol, with the RRE and cPPT/CTS, so it supplies the packaging proteins in trans for lentiviral vectors. Deposited by the Weinberg lab as Addgene #8455.

Characteristics

13,380 bp circular plasmid with ampicillin resistance in bacteria. The file annotates the CMV enhancer and promoter, HIV-1 gag (1,503 bp) and pol (3,012 bp), cPPT/CTS, the RRE, a gp41 peptide fragment, an NES, and an SV40 promoter and origin with a small t intron and SV40 NLS. Stewart and colleagues produced Lentihair by co-transfecting a CMV-driven R8.20 vpr packaging plasmid with the VSV-G plasmid pHCMVG, and Addgene credits that paper for this plasmid.

Applications

Supplying HIV-1 packaging functions (gag and pol) for lentiviral vector production, by co-transfection into HEK293T or HEK293FT cells with the envelope plasmid pCMV-VSV-G (Addgene #8454) and a transfer vector. Reported uses: shRNA and CRISPR-Cas9 knockout vectors (c-Myc shRNA in prostate cancer cells; integrin-targeting LentiCRISPR v2 in glioblastoma stem cells; PUM2 shRNA; Rack1 shRNA in mouse macrophages), cDNA and microRNA expression vectors (miR-23b in brain microvascular endothelial cells), a tdTomato reporter vector for human embryonic stem cells, and QuasAr voltage-indicator variants for transduction of primary hippocampal neurons.

Validated In

Used as the packaging plasmid in HEK293T or HEK293FT cells, with pCMV-VSV-G, to produce lentivirus that transduced: human induced pluripotent stem cells (15 µg pCMV-dR8.2 dvpr, 3.75 µg pCMV-VSV-G and 11.25 µg transfer plasmid per 150 cm2 dish, Gata6 liver bud study); human embryonic stem cells (tdTomato vector, post-implantation embryo model study); primary hippocampal neurons (QuasAr voltage indicator screen); glioblastoma stem cells (GSC3565, LentiCRISPR v2 guides); prostate cancer cells 22Rv1, LNCaP95 and VCaP (c-Myc shRNA, DNA ratio 6:5:1 vector:dR8.2:VSV-G); cells knocked down for PUM2 (shRNA, ratio 4:3:1 vector:packaging:envelope, HEK293T producer cells, puromycin selection); mouse macrophages (Rack1 shRNA, HEK293T producer cells); and human brain microvascular endothelial cells HBMEC and hCMEC/D3 (miR-23b, puromycin selection). A genome-wide screen study for SARS-CoV-2 and common cold coronavirus host factors produced lentivirus in HEK293FT cells with pCMV-dR8.2 dvpr, pCMV-VSV-G and pAdVAntage, and selected transduced cells with puromycin or hygromycin. One paper (miR-23b) lists the plasmid as pCMV-DR8.74 with Addgene #8455.

Payload22 features

in a 13,380 bp deposit · 5 features outside the design

0500010000pCMV-dR8.2 dvprPlasmid DNA · 46% GCCMV enhancer · enhancer · 2,374–2,753 · 380 bpCMV enhancerCMV promoter · promoter · 2,754–2,957 · 204 bpCMV promoterHIV-1 gag · CDS · 3,228–4,730 · 1,503 bpHIV-1 gagHIV-1 pol · CDS · 4,523–7,534 · 3,012 bpHIV-1 polcPPT/CTS · other · 7,219–7,336 · 118 bpcPPT/CTSRRE · other · 8,831–9,064 · 234 bpRREgp41 peptide · CDS · 9,249–9,293 · 45 bpgp41 peptideNES · CDS · 9,587–9,613 · 27 bpNESSP6 promoter · promoter · 10,850–10,868 (reverse) · 19 bpSP6 promoterSV40 promoter · promoter · 246–575 · 330 bpSV40 promoterSV40 ori · origin · 426–561 · 136 bpSV40 orismall t intron · intron · 1,709–1,774 · 66 bpsmall t intronSV40 NLS · CDS · 1,904–1,924 · 21 bpSV40 NLSSV40 late intron · intron · 1,702–1,794 · 93 bpSV40 late intron0200040006000800010000pCMV-dR8.2 dvprPlasmid DNA · 46% GCCMV enhancer · enhancer · 2,374–2,753 · 380 bpCMV enhancerCMV promoter · promoter · 2,754–2,957 · 204 bpCMV promoterHIV-1 gag · CDS · 3,228–4,730 · 1,503 bpHIV-1 gagHIV-1 pol · CDS · 4,523–7,534 · 3,012 bpHIV-1 polcPPT/CTS · other · 7,219–7,336 · 118 bpcPPT/CTSRRE · other · 8,831–9,064 · 234 bpRREgp41 peptide · CDS · 9,249–9,293 · 45 bpgp41 peptideNES · CDS · 9,587–9,613 · 27 bpNESSP6 promoter · promoter · 10,850–10,868 (reverse) · 19 bpSP6 promoterSV40 promoter · promoter · 246–575 · 330 bpSV40 promoterSV40 ori · origin · 426–561 · 136 bpSV40 orismall t intron · intron · 1,709–1,774 · 66 bpsmall t intronSV40 NLS · CDS · 1,904–1,924 · 21 bpSV40 NLSSV40 late intron · intron · 1,702–1,794 · 93 bpSV40 late intron0200040006000800010000pCMV-dR8.2 dvprPlasmid DNA · 46% GCCMV enhancer · enhancer · 2,374–2,753 · 380 bpCMV enhancerCMV promoter · promoter · 2,754–2,957 · 204 bpCMV promoterHIV-1 gag · CDS · 3,228–4,730 · 1,503 bpHIV-1 gagHIV-1 pol · CDS · 4,523–7,534 · 3,012 bpHIV-1 polcPPT/CTS · other · 7,219–7,336 · 118 bpcPPT/CTSRRE · other · 8,831–9,064 · 234 bpRREgp41 peptide · CDS · 9,249–9,293 · 45 bpgp41 peptideNES · CDS · 9,587–9,613 · 27 bpNESSP6 promoter · promoter · 10,850–10,868 (reverse) · 19 bpSP6 promoterSV40 promoter · promoter · 246–575 · 330 bpSV40 promoterSV40 ori · origin · 426–561 · 136 bpSV40 orismall t intron · intron · 1,709–1,774 · 66 bpsmall t intronSV40 NLS · CDS · 1,904–1,924 · 21 bpSV40 NLSSV40 late intron · intron · 1,702–1,794 · 93 bpSV40 late intron

Sequence11,655 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Stewart et al. (2003). Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA — Stewart 2003 Lentiviral RNAi

Identifiers & revision